Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.
暂无分享,去创建一个
[1] E. Perez,et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer , 2012, Cancer.
[2] S. Edge,et al. Impact of body mass index on clinical outcomes in triple‐negative breast cancer , 2011, Cancer.
[3] R. Prentice,et al. Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor–Positive Breast Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[4] Charles M Perou,et al. Molecular stratification of triple-negative breast cancers. , 2010, The oncologist.
[5] C. Sweeney,et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.
[7] A. Onitilo,et al. Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival , 2009, Clinical Medicine & Research.
[8] S. Narod,et al. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers , 2009, Breast Cancer Research and Treatment.
[9] G. Hortobagyi,et al. Prognostic Value of Body Mass Index in Locally Advanced Breast Cancer , 2008, Clinical Cancer Research.
[10] K. Hess,et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] S. Narod,et al. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.
[12] C. Perou,et al. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.
[13] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[14] G. Hortobagyi,et al. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] C. Caldas,et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] P. Wingo,et al. Body Mass and Mortality After Breast Cancer Diagnosis , 2005, Cancer Epidemiology Biomarkers & Prevention.
[17] Graham A. Colditz,et al. Physical activity and survival after breast cancer diagnosis , 2005 .
[18] Therese Sørlie,et al. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. , 2004, European journal of cancer.
[19] L. Goldstein,et al. Prognostic and predictive factors in early-stage breast cancer. , 2004, The oncologist.
[20] S. Cummings,et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.
[21] S. Edge,et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. , 2003, The Surgical clinics of North America.
[22] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[23] M. Thun,et al. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women , 2002, Cancer Causes & Control.
[24] Cathy J Bradley,et al. Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.
[25] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] E. Winer,et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[28] A. Lethaby,et al. Survival of women with node negative breast cancer in the Auckland region. , 1996, The New Zealand medical journal.
[29] William H. Hartmann,et al. The World Health Organization Histological Typing of Breast Tumors—Second Edition , 1982 .
[30] Black Mm,et al. Nuclear structure in cancer tissues. , 1957 .
[31] M. Ewertz,et al. Effect of obesity on prognosis after early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] K. Hess,et al. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. , 2011, The oncologist.
[33] S. Tretli,et al. Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients , 2005, Breast Cancer Research and Treatment.
[34] I. Prpić-Križevac,et al. Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. , 1998, Metabolism: clinical and experimental.
[35] L. Holmberg,et al. Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer. , 1994, European journal of cancer.
[36] The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization. , 1982, American journal of clinical pathology.